ArticleFrontiers in medicine2022

Dupilumab modulates specific IgE mite responses at the molecular level in severe T2-high atopic dermatitis: A real-world experience.

Ruperto González-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.